Drug Type Small molecule drug |
Synonyms Acetazolamide/Atomoxetine, AD-981 |
Target |
Action inhibitors |
Mechanism CAs inhibitors(Carbonic anhydrases inhibitors), NET inhibitors(Norepinephrine transporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC4H6N4O3S2 |
InChIKeyBZKPWHYZMXOIDC-UHFFFAOYSA-N |
CAS Registry59-66-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity Hypoventilation Syndrome | Phase 2 | Italy | 21 Jun 2022 | |
| Obesity Hypoventilation Syndrome | Phase 2 | Italy | 21 Jun 2022 |





